Biocon arm wins Asia IP Elite Award Ruchika Sharma12 Nov 2022 7:30 AMA record 80 organisations around the Asia-Pacific region featured in this year's event, which was organized after a gap of two years.
Biocon net profit up 71 pc to Rs 144 crore in June quarter MD Bureau28 July 2022 4:57 AMNew Delhi: Biotechnology major Biocon on Wednesday reported a 71 per cent increase in consolidated net profit at Rs 144 crore for the June quarter on...
Insulin Glargine Induces Less Insulin Antibody Than Other Insulin Regimens MD Bureau11 March 2022 4:30 AMInsulin antibodies (IAs), which were found commonly developed in patients treated with exogenous insulin, might affect glycemic control due to their...
Biocon Biologics, Viatris interchangeable biosimilar Insulin Glargine preferred on Express Scripts' largest formulary in US Ruchika Sharma21 Oct 2021 9:58 AMBengaluru: Biocon Biologics Limited, a subsidiary of Biocon Ltd. has recently announced that Express Scripts, a pharmacy benefit management...
Long acting insulin analogue tied to low risk of sudden fall of blood sugar: JAMA Medha Baranwal5 March 2021 6:15 AMUSA: The use of long-acting insulin analogs versus NPH insulin lowers the risk of severe hypoglycemia in older patients with type 2 diabetes...
Biocon Biologics gets EU GMP Certification for Drug Substance Facilities, Bengaluru Ruchika Sharma13 May 2020 6:14 AMBengaluru: Biocon Biologics India Ltd., a subsidiary of Biocon Ltd. has received the Certificate of GMP compliance from EMA represented by the...
